Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymic involution in aging. Prospects for correction.

J W Hadden1, P H Malec, J Coto

  • 1Division of Immunopharmacology, University of South Florida Medical College, Tampa 33612.

Annals of the New York Academy of Sciences
|December 26, 1992
PubMed
Summary

Interleukin (IL) administration, but not thymosin, rejuvenated the thymus in aged mice, restoring thymic weight and enhancing T cell development. This suggests ILs can counteract age-related immune decline.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclic nucleotides in mitogen-induced lymphocyte proliferation.

Immunology today·2014
Same author

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.

Cell death and differentiation·2009
Same author

IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.

Annals of the New York Academy of Sciences·2007
Same author

Neuroendocrine immune interactions in health and disease.

International immunopharmacology·2003
Same author

A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma.

International immunopharmacology·2002
Same author

Immunomodulatory properties of Mycoplasma pulmonis. I. Characterization of the immunomodulatory activity.

International immunopharmacology·2001

Area of Science:

  • Immunology
  • Endocrinology
  • Aging Research

Background:

  • The thymus produces hormones crucial for T cell development, but these decline with age, leading to immune senescence.
  • Intrathymic and extrathymic signals, including thymic peptides and interleukins (ILs), regulate T cell maturation.
  • Age-related decline in thymic function contributes to disease in the elderly.

Purpose of the Study:

  • To investigate if exogenous interleukins (ILs) can restore T lymphocyte development in aged mice.
  • To compare the effects of mixed interleukins versus thymic hormones on thymic function in aging.

Main Methods:

  • Aged mice were chemically thymectomized using a steroid hormone.
  • Mice were treated with either mixed interleukins or thymosin.

Related Experiment Videos

  • Thymic weight, cellularity, and thymocyte responses to ILs and mitogens were assessed.

    • Main Results:

    • Mixed interleukins significantly restored thymic weight and cellularity in aged mice.
    • Interleukin treatment enhanced thymocyte responses to ILs and mitogens.
    • Thymosin alone did not restore thymic function but potentiated the effects of interleukins.

    Conclusions:

    • Exogenous administration of interleukins can reverse age-related thymic involution and enhance T cell development.
    • Interleukins show promise in combating immune senescence and age-associated diseases.
    • A combination of interleukins and thymic hormones may offer synergistic benefits for immune restoration.